181 related articles for article (PubMed ID: 17564747)
1. Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer.
Yao MS; Kurland BF; Smith AH; Schubert EK; Dunnwald LK; Byrd DR; Mankoff DA
Ann Surg Oncol; 2007 Oct; 14(10):2985-93. PubMed ID: 17564747
[TBL] [Abstract][Full Text] [Related]
2. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
[TBL] [Abstract][Full Text] [Related]
4. Prediction of axillary metastases in breast cancer by lymphoscintigraphy.
Black RB; Merrick MV; Taylor TV; Forrest AP
Lancet; 1980 Jul; 2(8184):15-7. PubMed ID: 6104225
[TBL] [Abstract][Full Text] [Related]
5. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer.
Cody HS; Urban JA
Ann Surg Oncol; 1995 Jan; 2(1):32-7. PubMed ID: 7834452
[TBL] [Abstract][Full Text] [Related]
6. Lack of efficacy of lymphoscintigraphy in detecting axillary lymph node metastases from breast cancer.
Gasparini M; Andreoli C; Rodari A; Costa A; Buraggi GL
Eur J Cancer Clin Oncol; 1987 May; 23(5):475-80. PubMed ID: 3653172
[TBL] [Abstract][Full Text] [Related]
7. Level of axillary involvement by lymph node metastases from breast cancer is not an independent predictor of survival.
Barth RJ; Danforth DN; Venzon DJ; Straus KL; d'Angelo T; Merino MJ; Gerber L
Arch Surg; 1991 May; 126(5):574-7. PubMed ID: 2021339
[TBL] [Abstract][Full Text] [Related]
8. High resolution sonographic detection of axillary lymph node metastases in breast cancer.
Yang WT; Ahuja A; Tang A; Suen M; King W; Metreweli C
J Ultrasound Med; 1996 Mar; 15(3):241-6. PubMed ID: 8919506
[TBL] [Abstract][Full Text] [Related]
9. Does the TNM classification of solitary internal mammary lymph node metastases in breast cancer still apply?
Habraken V; van Nijnatten TJ; de Munck L; Moossdorff M; Heuts EM; Lobbes MB; Smidt ML
Breast Cancer Res Treat; 2017 Feb; 161(3):483-489. PubMed ID: 27915433
[TBL] [Abstract][Full Text] [Related]
10. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.
Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
Arch Surg; 1993 Feb; 128(2):242-6. PubMed ID: 8094282
[TBL] [Abstract][Full Text] [Related]
11. The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis.
Gaglia P; Bussone R; Caldarola B; Lai M; Jayme A; Caldarola L
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):849-54. PubMed ID: 3653201
[TBL] [Abstract][Full Text] [Related]
12. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases.
Mansi L; Rambaldi PF; Procaccini E; Gregorio FD; Laprovitera A; Pecori B; Vecchio WD
Eur J Nucl Med; 1996 Aug; 23(8):932-9. PubMed ID: 8753682
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of breast cancer: evidence for interaction between c-erbB-2 overexpression and number of involved axillary lymph nodes.
Mittra I; Redkar AA; Badwe RA
J Surg Oncol; 1995 Oct; 60(2):106-11. PubMed ID: 7564375
[TBL] [Abstract][Full Text] [Related]
14. The relevance of internal mammary lymphoscintigraphy in the management of breast carcinoma.
Ege GN; Elhakim T
J Clin Oncol; 1984 Jul; 2(7):774-81. PubMed ID: 6737019
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the prognostic value of triple node biopsy in early breast cancer.
Du Toit RS; Locker AP; Ellis IO; Elston CW; Blamey RW
Br J Surg; 1990 Feb; 77(2):163-7. PubMed ID: 2317676
[TBL] [Abstract][Full Text] [Related]
16. Axillary lymphoscintigraphy: current status in the treatment of breast cancer.
Frühling JG; Bourgeois P
Crit Rev Oncol Hematol; 1983; 1(1):1-20. PubMed ID: 6394166
[TBL] [Abstract][Full Text] [Related]
17. Internal mammary lymphoscintigraphy: current status in the treatment of breast cancer.
Bourgeois P; Frühling JG
Crit Rev Oncol Hematol; 1983; 1(1):21-47. PubMed ID: 6394167
[TBL] [Abstract][Full Text] [Related]
18. The detection of internal mammary lymph nodal chain metastases in breast cancer using radiolabelled colloids.
Inga G; Pepe G; Caruso M; Sportelli S; Pepe F; Panella P
Eur J Gynaecol Oncol; 1987; 8(2):105-9. PubMed ID: 3569327
[TBL] [Abstract][Full Text] [Related]
19. Internal mammary lymphoscintigraphy in the conservative management of breast carcinoma: an update and recommendations for a new TNM staging.
Ege GN; Clark RM
Clin Radiol; 1985 Sep; 36(5):469-72. PubMed ID: 4075713
[TBL] [Abstract][Full Text] [Related]
20. Axillary nodal disease burden is not associated with an elevated 21-gene recurrence score in post-menopausal women presenting with a clinically negative axilla.
Botty van den Bruele A; Paul MA; Thomas SM; Sammons SL; DiNome ML; Plichta JK; Record SM; Woriax H; Chiba A; Rosenberger LH; Hwang ES
Am J Surg; 2024 Jul; 233():45-51. PubMed ID: 38350748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
